WELLS FARGO & COMPANY/MN - BALCHEM CORP ownership

BALCHEM CORP's ticker is BCPC and the CUSIP is 057665200. A total of 230 filers reported holding BALCHEM CORP in Q3 2019. The put-call ratio across all filers is 0.37 and the average weighting 0.3%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of BALCHEM CORP
ValueSharesWeighting
Q3 2023$4,909,809
-20.9%
39,583
-14.0%
0.00%
-50.0%
Q2 2023$6,207,482
+27.0%
46,047
+19.1%
0.00%
+100.0%
Q1 2023$4,889,328
+26.4%
38,656
+22.1%
0.00%0.0%
Q4 2022$3,866,797
-3.6%
31,667
-4.0%
0.00%0.0%
Q3 2022$4,013,000
-4.8%
33,003
+1.5%
0.00%0.0%
Q2 2022$4,217,000
-39.0%
32,510
-35.7%
0.00%
-50.0%
Q1 2022$6,911,000
-33.5%
50,553
-18.0%
0.00%
-33.3%
Q4 2021$10,399,000
-53.1%
61,681
-59.6%
0.00%
-40.0%
Q3 2021$22,175,000
+9.2%
152,859
-1.2%
0.01%
+25.0%
Q2 2021$20,310,000
-10.9%
154,736
-14.9%
0.00%
-20.0%
Q1 2021$22,790,000
+4.5%
181,725
-4.0%
0.01%0.0%
Q4 2020$21,819,000
+48.9%
189,372
+26.2%
0.01%
+25.0%
Q3 2020$14,652,000
-4.7%
150,075
-7.4%
0.00%0.0%
Q2 2020$15,380,000
+6.2%
162,141
+10.5%
0.00%
-20.0%
Q1 2020$14,488,000
+43.8%
146,761
+48.0%
0.01%
+66.7%
Q4 2019$10,078,000
-7.2%
99,163
-9.4%
0.00%0.0%
Q3 2019$10,857,000
+4.4%
109,461
+5.2%
0.00%0.0%
Q2 2019$10,399,000
+5.2%
104,019
-2.3%
0.00%0.0%
Q1 2019$9,885,000
+18.2%
106,514
-0.2%
0.00%0.0%
Q4 2018$8,365,000
+3.3%
106,761
+47.7%
0.00%
+50.0%
Q3 2018$8,101,000
+21.6%
72,272
+6.5%
0.00%0.0%
Q2 2018$6,663,000
+3.4%
67,889
-13.9%
0.00%0.0%
Q1 2018$6,447,000
+7.1%
78,864
+5.6%
0.00%0.0%
Q4 2017$6,018,000
-26.8%
74,669
-26.2%
0.00%
-33.3%
Q3 2017$8,226,000
-3.2%
101,188
-7.5%
0.00%0.0%
Q2 2017$8,499,000
-21.5%
109,366
-16.8%
0.00%
-25.0%
Q1 2017$10,833,000
+8.4%
131,424
+10.3%
0.00%0.0%
Q4 2016$9,995,000
+105.9%
119,099
+90.2%
0.00%
+100.0%
Q3 2016$4,854,000
-21.1%
62,609
-39.3%
0.00%0.0%
Q2 2016$6,149,000
-40.4%
103,093
-38.0%
0.00%
-50.0%
Q1 2016$10,315,000
-7.6%
166,313
-9.4%
0.00%0.0%
Q4 2015$11,164,000
+1.3%
183,637
+1.2%
0.00%
-20.0%
Q3 2015$11,021,000
+12.2%
181,375
+2.9%
0.01%
+25.0%
Q2 2015$9,824,000
-65.2%
176,319
-65.5%
0.00%
-33.3%
Q1 2015$28,268,000
+9.2%
510,424
+31.3%
0.01%
-40.0%
Q4 2014$25,895,000
+41.8%
388,601
+20.4%
0.01%
+25.0%
Q3 2014$18,259,000
+58.8%
322,751
+50.4%
0.01%
+60.0%
Q2 2014$11,496,000
+3.6%
214,636
+0.8%
0.01%0.0%
Q1 2014$11,094,000
-0.1%
212,859
+12.6%
0.01%0.0%
Q4 2013$11,102,000
+13.8%
189,117
+0.3%
0.01%0.0%
Q3 2013$9,754,000
+16.7%
188,500
+0.9%
0.01%
+25.0%
Q2 2013$8,358,000186,7590.00%
Other shareholders
BALCHEM CORP shareholders Q3 2019
NameSharesValueWeighting ↓
SANTA MONICA PARTNERS LP 425,686$49,048,00036.25%
Conestoga Capital Advisors, LLC 939,134$108,207,0001.72%
Tributary Capital Management, LLC 197,207$22,722,0001.63%
Ellsworth Advisors, LLC 16,335$1,882,0001.36%
GENEVA CAPITAL MANAGEMENT LLC 693,677$79,926,0001.35%
Brown Capital Management 1,391,418$160,319,0001.11%
BARD ASSOCIATES INC 107,550$12,390,0000.98%
Advantage Alpha Capital Partners LP 38,370$4,421,0000.97%
MOODY ALDRICH PARTNERS LLC 50,270$5,792,0000.94%
Cutter & CO Brokerage, Inc. 29,369$3,384,0000.89%
View complete list of BALCHEM CORP shareholders